In this study, we identified the transcription factor YY1, linked to resistance to PD‐1 therapy in HCC, and demonstrated its role in fostering drug resistance by upregulating PD‐L1 expression in liver cancer cells. The gene discussed is YY1; the disease is hepatocellular carcinoma.